IAGS 2012 Program Agenda
The Journal of Invasive Cardiology, serving as the official journal of the International Andreas Gruentzig Society, will publish the highlights and discussion from this meeting during the months ahead. Here is a list of topics discussed at the recent IAGS biennial meeting.
International Andreas Gruentzig Society (IAGS)
2012 Program Agenda
Monday, January 30, 2012
Coronary: Pharma / Intervention / Imaging
Are Bio-Erodable Stents the Perfect Stent?
Speaker: Jamey Jacobs
Moderator: Kirk Garratt
Panelists: Howard Cohen
Jeffrey Westcott
Are Polymer-Free Durable Stents The Perfect Stent?
Speaker: Steve Bailey
Moderator: Alfredo Rodriguez
Panelists: Jorge Belardi
Ariel Duran
Coronary: Pharma / Intervention / Imaging
What Should We Expect from Current and Future Oral Antiplatelet Drugs?
Speaker: Tarek Helmy
Moderator: Larry Dean
Panelists: Stefan Beyer-Enke
Bonnie Weiner
Optimal Duration of Dual Antiplatelet Therapy? Will On-Going Studies / DAPT Tell Us?
Speaker: Skip Anderson
Moderator: Mike Cowley
Panelists: George Vetrovec
Michael Mooney
Adam Greenbaum
Session 2: New Technologies
Should We Expand Use of Hypothermia Into Non-OHA Patients?
Speaker: Mike Mooney
Moderator: Dick Shaw
Panelists: Rita Watson,
Tim Henry
Can Afferent Nerve Ablation Cure Essential Hypertension?
Speaker: Jeffrey Westcott
Moderator: Robert Bersin
Panelists: Jim Zidar
William O’Neill
New Catheter Based Techniques – PFO Closure
Speaker: Steve Bailey
Moderator: Larry Dean
Panelists: Jiri Vitek
Tyrone Collins
Interventional Radiology
Intra-Cranial Intervention: Embolization, Balloons, Stents
Speaker: Gyula Gal
Moderator: Tyrone Collins
Panelists: Nick Hopkins
Gary Roubin
Acute Stroke Intervention: Where Do We Stand
Speaker: Nick Hopkins
Moderator: Richard Gray
Panelists: Barry Katzen,
Jiri Vitek
Massive Pulmonary Embolization: What is Optimal Treatment?
Speaker: GianPietro Feltrin
Moderator: Kirk Garratt
Panelists: Souheil Saddekni
Mesenteric and Celiac Intervention and Interventional Oncology
Speaker: Souheil Saddekni
Moderator: Barry Katzen
Panelists: GianPietro Feltrin
Peripheral / Carotid
Why CREST is a Game Changer for Carotid Revascularization
Speaker: Gary Roubin
Moderator: Nick Hopkins
Panelists: Jiri Vitek,
Tyrone Collins
Better Results with New Technology: The Global Strategies Roundtable
Speaker: Tyrone Collins
Moderator: Robert Bersin
Panelists: Nick Hopkins
How to Design the Next Carotid Revascularization Trial
Speaker: Roundtable
Moderator: Gary Roubin
Panelists: Barry Katzen
Tuesday, January 30, 2012
Regenerative Medicine
How Does Angiogenic Cell Therapy Really Work?
Speaker: Sigrid Nikol
Moderator: Amir Lerman
Panelists: Tim Henry
Can Gene and Stem Cell Therapies be Combined?
Speaker: Tim Henry
Moderator: Sigrid Nikol
Panelists: Amir Lerman,
Kirk Garratt
Can Functionomics Improve Risk Assessment?
Speaker: Amir Lerman
Moderator: Kirk Garratt
Panelists: Sigrid Nikol
Coronary: Pharma / Intervention / Imaging
Will Drug-Eluting Balloons Have a Role in Treating CAD Without Stents?
Speaker: Alfredo Rodriguez
Moderator: Larry Dean
Panelists: Mike Mooney
Ariel Duran
PCI for Left Main Disease? Do We Need More Trials?
Speaker: Bonnie Weiner
Moderator: Mike Cowley
Panelists: Jeff Marshall
Norberto Schechtmann
Tarek Helmy
Coronary: Pharma / Intervention / Imaging
Are CTO’s Worth the Extraordinary Efforts Being Made in Japan Today?
Speaker: Larry Dean
Moderator: Adam Greenbaum
Panelists: Jeff Marshall
Jeffrey Westcott
Can We Use Newer Fluoroscopic Imaging Systems to Improve Safety and Procedure Success?
Speaker: Stefan Beyer-Enke
Moderator: Matt Shaner
Panelists: James Adams
Jan Boese
New Technologies
Should We Expand Use of Left Ventricular Support in AMI and High Risk Patients?
Speaker: Howard Cohen
Moderator: William O’Neill
Panelists: George Vetrovec
Bryan Ristow
Should We Incorporate Remote Ischemic Pre-Conditioning in Care of AMI Patients?
Speaker: Kirk Garratt
Moderator: Amir Lerman
Panelists: Sigrid Nikol,
Tim Henry
New Technologies
Can Progenitor-Cell Capturing Stent Methods make Drug Elution Obsolete?
Speaker: Amir Lerman
Moderator: Sigrid Nikol
Panelists: Tim Henry
Will Stents Designed to Treat Bifurcation Disease Make Any Difference?
Speaker: Jorge Belardi
Moderator: Howard Cohen
Panelists: Adam Greenbaum,
Bryan Ristow
Interventional Radiology
Critical Limb Ischemia and Below Knee PTA
Speaker: Robert Bersin
Moderator: James Benenati
Panelists: James Zidar,
Tyrone Collins
Challenges with SFA: CTO, Restenosis, Drug Eluting Balloons and Devices
Speaker: Barry Katzen
Moderator: Tyrone Collins
Panelists: James Benenati
Interventional Radiology
Advances in Treatment of Thoracic and Abdominal Aneurysms and Endoleaks
Speaker: James Benenati
Moderator: Barry Katzen
Panelists: Robert Bersin,
Souheil Saddekni,
Andrew Cragg
Renal Interventions: Is the Evidence Base Convincing?
Speaker: Tyrone Collins
Moderator: Jim Zidar
Panelists: Gary Roubin
Wednesday, February 1, 2012
Peripheral / Lower Extremity
Drug Eluting Stents for the SFA – Finally a Solution to Restenosis
Speaker: Robert Bersin
Moderator: Barry Katzen
Panelists: James Benenati
SFA Best Techniques – Getting Them Open – Keeping Them Open
Speaker: Roundtable
Moderator: Sigrid Nikol
Panelists: Andrew Cragg,
Jim Zidar
Infrapopliteal Disease and Limb Salvage: new Technology and Techniques
Speaker: none/ Roundtable
Moderator: John Brumieve
Panelists: Souheil Saddekni,
Eric Dufford,
David Williams
New Technologies
Challenges to TVAR Becoming the Standard of Care for AVR
Speaker: William O’Neill
Moderator: Alex Zapolanski
Panelists: Tarek Helmy
Will Percutaneous Device Placement Become the New Standard for MVR?
Speaker: Steve Bailey
Moderator: Larry Dean
Panelists: Tim Henry
Jeff Marshall
Coronary: Pharma / Intervention / Imaging
How Should Recent DES Recipients Needing Surgery Be Managed?
Speaker: Mike Mooney
Moderator: George Vetrovec
Panelists: Rita Watson
Tony Dortimer
Bryan Ristow
What is the Optimal Management of Patients Needing DAPT and Anticoagulation?
Speaker: Skip Anderson
Moderator: Rita Watson
Panelists: Bonnie Weiner
Norberto Schechtmann
Richard Gray
Regenerative Medicine
What Barriers Remain for Routinely Using Gene Therapy in Vascular Disease?
Speaker: Sigrid Nikol
Moderator: Tim Henry
Panelists: Kirk Garratt
Industry Roundtable
How Will Changing Government Healthcare Rules Affect Physician-Industry Relations?
Speaker: Roundtable
Moderator: Dick Shaw
Panelists: Richard Gray,
Barry Katzen,
Karim Benali,
Bonnie Weiner
Evelyn Baram-Clothier
Mike Martinell
How Can Physicians and Industry Be More Effective in Speeding Product Evaluation and Development?
Speaker: Roundtable
Moderator: Gary Roubin
Panelists: John Brumieve
Jamey Jacobs
Tricia Todd
Max Muhs
Andrew Cragg
Healthcare Reform
A View from the Trenches: Reimbursement is Driving Change
Speaker: Dick Shaw
Moderator: Richard Gray
Panelists: Jeff Marshall,
Mike Martineli
Wringing Out Excess Costs in CV Care: What Can We Do?
Speaker: Barry Katzen
Moderator: Kirk Garratt
Panelists: Robert Bersin
